VEGFA and liver cancer: Previous reports indicate that NOX4 not only promotes angiogenesis via endothelial nitric oxide synthase activation, HIF-1α-mediated angiogenesis, and VEGF expression, but also inhibits the epithelial-to-mesenchymal transition to attenuate liver cancer progression21, 27–29.